
GEHC
Healthcare · Medical Devices · $37.54B market cap
$83.02+1.18 (+1.4%)Nov 13, 4:08 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -2.3% over 90 days · 30-day revisions 1 up, 12 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 28, 2026 | Before the open | 1.21 | 1.34 | +10.7% |
| Jul 29, 2026 | Before the open | 1.04 | 1.13 | +8.7% |
| Apr 29, 2026 | Before the open | 1.05 | 0.99 | -5.7% |
| Feb 4, 2026 | Before the open | 1.40 | 1.44 | +2.9% |
| Oct 29, 2025 | Before the open | 1.05 | 1.07 | +1.9% |
| Jul 30, 2025 | Before the open | 0.92 | 1.06 | +15.2% |
| Apr 30, 2025 | Before the open | 0.91 | 1.01 | +11.0% |
| Feb 13, 2025 | Time not confirmed | 1.26 | 1.57 | +24.6% |
| Oct 30, 2024 | Before the open | 1.05 | 1.14 | +8.6% |
| Jul 31, 2024 | Before the open | 0.98 | 1.00 | +2.0% |
| Apr 30, 2024 | Before the open | 0.91 | 0.90 | -1.1% |
| Feb 6, 2024 | Before the open | 1.07 | 1.18 | +10.3% |
| Oct 31, 2023 | Before the open | 0.90 | 0.99 |
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).…
| +10.0% |
| Jul 25, 2023 | Before the open | 0.87 | 0.92 | +5.7% |
| Apr 25, 2023 | Before the open | 0.79 | 0.85 | +7.6% |
| Jan 30, 2023 | Before the open | 1.06 | 1.21 | +14.2% |
| Dec 8, 2022 | After the close | 0.00 | 1.11 | — |
| Sep 13, 2022 | Time not confirmed | — | 1.90 | — |